Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Grade Last Price % Change Price Change
grade D 2.44 2.09% 0.05
CANF closed up 2.09 percent on Friday, November 15, 2019, on 9 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CANF trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 2.09%
50 DMA Support Bullish 2.09%
20 DMA Support Bullish 2.95%
50 DMA Support Bullish 2.95%
Narrow Range Bar Range Contraction 2.95%
Bearish Engulfing Bearish 0.83%
Outside Day Range Expansion 0.83%
Narrow Range Bar Range Contraction -1.61%
NR7 Range Contraction -1.61%
NR7-2 Range Contraction -1.61%

Older signals for CANF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.
Medicine Biotechnology Cancer Medical Specialties Immunology Treatment Of Cancer Psoriasis Rheumatoid Arthritis Glaucoma Inflammatory Diseases Arthritis Immunosuppressants Hepatocellular Carcinoma Uveitis Biotie Therapies Treatment Of Inflammatory Diseases Treatment Of Psoriasis
Is CANF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.95
52 Week Low 1.9
Average Volume 386,727
200-Day Moving Average 6.2936
50-Day Moving Average 2.3132
20-Day Moving Average 2.3135
10-Day Moving Average 2.401
Average True Range 0.2116
ADX 47.34
+DI 37.9048
-DI 11.4957
Chandelier Exit (Long, 3 ATRs ) 3.3652
Chandelier Exit (Short, 3 ATRs ) 2.6807
Upper Bollinger Band 2.5616
Lower Bollinger Band 2.0654
Percent B (%b) 0.75
BandWidth 21.448022
MACD Line 0.0414
MACD Signal Line 0.0284
MACD Histogram 0.0129
Fundamentals Value
Market Cap 42.36 Million
Num Shares 17.4 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -4.78
Price-to-Sales 132.22
Price-to-Book 7.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.64
Resistance 3 (R3) 2.62 2.53 2.60
Resistance 2 (R2) 2.53 2.48 2.54 2.59
Resistance 1 (R1) 2.49 2.45 2.51 2.51 2.58
Pivot Point 2.40 2.40 2.42 2.41 2.40
Support 1 (S1) 2.36 2.35 2.38 2.38 2.30
Support 2 (S2) 2.27 2.32 2.28 2.29
Support 3 (S3) 2.23 2.27 2.28
Support 4 (S4) 2.25